Related Experiment Video
Updated: Apr 20, 2026
Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
SMAD4 and its role in pancreatic cancer
Xiang Xia1, Weidong Wu, Chen Huang
1Department of General Surgery, Shanghai Jiaotong University Affiliated First People's Hospital, 100 Hai Ning Road, Shanghai, 200080, People's Republic of China.
Abstract:
Transforming growth factor-β (TGF-β) regulates cell functions and has key roles in pancreatic cancer development. SMAD4, as one of the Smads family of signal transducer from TGF-β, mediates pancreatic cell proliferation and apoptosis and is specifically inactivated in half of advanced pancreatic cancers. In recent years, many advances concerning SMAD4 had tried to unravel the complex signaling mechanisms of TGF-β and its dual role of tumor-suppressive and tumor-promoting efforts in pancreatic cancer initiation and progression through SMAD4-dependent TGF-β signaling and SMAD4-independent TGF-β signaling pathways. Meanwhile, its potential prognostic value based on immunohistochemical expression in surgical sample was variably reported by several studies and short of a systematic analysis. This review aimed to discuss the structure, functions, and regulation of this principal protein and its effects in determining the progression and prognosis of pancreatic cancer.
Insights
Transforming growth factor-β (TGF-β) signaling, particularly SMAD4's role, is crucial in pancreatic cancer. Understanding SMAD4's function and prognostic value is key for advancing pancreatic cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Cell Signaling
Background:
- Transforming growth factor-β (TGF-β) is a key regulator of cell functions with significant roles in pancreatic cancer.
- SMAD4, a crucial signal transducer for TGF-β, influences pancreatic cell proliferation and apoptosis, and is inactivated in approximately half of advanced pancreatic cancers.
- Recent research explores SMAD4-dependent and independent TGF-β signaling pathways, highlighting TGF-β's dual role in pancreatic cancer initiation and progression.
Purpose of the Study:
- To review the structure, functions, and regulation of SMAD4.
- To elucidate the effects of SMAD4 in pancreatic cancer progression and prognosis.
- To systematically analyze the prognostic value of SMAD4 expression in surgical samples.
Main Methods:
- Literature review of studies on SMAD4 and TGF-β signaling in pancreatic cancer.
- Analysis of SMAD4's role in both SMAD4-dependent and independent TGF-β pathways.
- Examination of immunohistochemical data regarding SMAD4 expression and patient outcomes.
Main Results:
- SMAD4 is a critical mediator of TGF-β signaling in pancreatic cells.
- Inactivation of SMAD4 is common in advanced pancreatic cancer.
- Evidence suggests SMAD4 has a dual role (tumor-suppressive and tumor-promoting) in pancreatic cancer.
- Prognostic value of SMAD4 expression is variable and requires systematic analysis.
Conclusions:
- SMAD4 plays a complex and significant role in pancreatic cancer development and progression.
- Further systematic investigation into SMAD4's prognostic value is warranted.
- Understanding SMAD4 signaling is essential for developing targeted therapies for pancreatic cancer.
